Unknown

Dataset Information

0

Alarmin IL-33 elicits potent TB-specific cell-mediated responses.


ABSTRACT: Tuberculosis (TB) still remains a major public health issue despite the current available vaccine for TB, Bacille Calmette Guerin (BCG). An effective vaccine against TB remains a top priority in the fight against this pandemic bacterial infection. Adequate protection against TB is associated with the development of TH1-type and CD8(+) T cell responses. One alarmin cytokine, interleukin 33 (IL-33), has now been implicated in the development of both CD4(+) TH1 and CD8(+) T cell immunity. In this study, we determined whether the administration of IL-33 as an adjuvant, encoded in a DNA plasmid, could enhance the immunogenicity of a TB DNA vaccine. We report that the co-immunization of IL-33 with a DNA vaccine expressing the Mycobacterium Tuberculosis (Mtb) antigen 85B (Ag85B) induced robust Ag85B-specific IFN? responses by ELISpot compared to Ag85B alone. Furthermore, these enhanced responses were characterized by higher frequencies of Ag85B-specific, multifunctional CD4(+) and CD8(+) T cells. Vaccination with IL-33 also increased the ability of the Ag85B-specific CD8(+) T cells to undergo degranulation and to secrete IFN? and TNF? cytokines. These finding highlights IL-33 as a promising adjuvant to significantly improve the immunogenicity of TB DNA vaccines and support further study of this effective vaccine strategy against TB.

SUBMITTER: Villarreal DO 

PROVIDER: S-EPMC4635936 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alarmin IL-33 elicits potent TB-specific cell-mediated responses.

Villarreal Daniel O DO   Siefert Rebekah J RJ   Weiner David B DB  

Human vaccines & immunotherapeutics 20150101 8


Tuberculosis (TB) still remains a major public health issue despite the current available vaccine for TB, Bacille Calmette Guerin (BCG). An effective vaccine against TB remains a top priority in the fight against this pandemic bacterial infection. Adequate protection against TB is associated with the development of TH1-type and CD8(+) T cell responses. One alarmin cytokine, interleukin 33 (IL-33), has now been implicated in the development of both CD4(+) TH1 and CD8(+) T cell immunity. In this s  ...[more]

Similar Datasets

| S-EPMC4130175 | biostudies-literature
| S-EPMC4339042 | biostudies-literature
| S-EPMC4579851 | biostudies-literature
| S-EPMC5875946 | biostudies-literature
2012-02-27 | E-GEOD-34392 | biostudies-arrayexpress
2014-06-03 | E-GEOD-58164 | biostudies-arrayexpress
| S-EPMC6079063 | biostudies-literature
2012-02-27 | GSE34392 | GEO
2014-06-03 | GSE58164 | GEO
| S-EPMC5458557 | biostudies-literature